Literature DB >> 21924872

Voxel-based morphometry of patients with schizophrenia or bipolar I disorder: a matched control study.

Gregory G Brown1, Jun-Seok Lee, Irina A Strigo, Michael P Caligiuri, M J Meloy, James Lohr.   

Abstract

Controlled trials provide critical tests of hypotheses generated by meta-analyses. Two recent meta-analyses have reported that gray matter volumes of schizophrenia and bipolar I patients differ in the amygdala, hippocampus, or perigenual anterior cingulate. The present magnetic resonance imaging study tested these hypotheses in a cross-sectional voxel-based morphometry (VBM) design of 17 chronic schizophrenia and 15 chronic bipolar patients and 21 healthy subjects matched for age, gender and duration of illness. Whole brain gray matter volume of both the schizophrenia and bipolar groups was smaller than among healthy control subjects. Regional voxel-wise comparisons showed that gray matter volume was smallest within frontal and temporal regions of both patient groups. Region of interest analyses found moderately large to large differences between schizophrenia and healthy subjects in the amygdala and hippocampus. There were no group differences in the perigenual anterior cingulate. When schizophrenia and bipolar groups were directly compared, the schizophrenia group showed smaller gray matter volumes in right subcortical regions involving the right hippocampus, putamen, and amygdala. The hippocampal and amygdala findings confirm predictions derived from recent meta-analyses. These structural abnormalities may be important factors in the differential manifestations of these two functional psychotic disorders. Published by Elsevier Ireland Ltd.

Entities:  

Mesh:

Year:  2011        PMID: 21924872      PMCID: PMC3196272          DOI: 10.1016/j.pscychresns.2011.05.005

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  59 in total

1.  The relationship between symptom severity and regional cortical and grey matter volumes in schizophrenia.

Authors:  Ragnar Nesvåg; Peter Saetre; Glenn Lawyer; Erik G Jönsson; Ingrid Agartz
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2009-02-04       Impact factor: 5.067

2.  Age, rapid-cycling, and pharmacotherapy effects on ventral prefrontal cortex in bipolar disorder: a cross-sectional study.

Authors:  Hilary P Blumberg; John H Krystal; Ravi Bansal; Andrés Martin; James Dziura; Kathleen Durkin; Laura Martin; Elizabeth Gerard; Dennis S Charney; Bradley S Peterson
Journal:  Biol Psychiatry       Date:  2006-01-18       Impact factor: 13.382

3.  Structural brain alterations in subjects at high-risk of psychosis: a voxel-based morphometric study.

Authors:  E M Meisenzahl; N Koutsouleris; C Gaser; R Bottlender; G J E Schmitt; P McGuire; P Decker; B Burgermeister; C Born; Maximilian Reiser; H-J Möller
Journal:  Schizophr Res       Date:  2008-04-25       Impact factor: 4.939

4.  Genetic liability to schizophrenia or bipolar disorder and its relationship to brain structure.

Authors:  Andrew M McIntosh; Dominic E Job; William J Moorhead; Lesley K Harrison; Heather C Whalley; Eve C Johnstone; Stephen M Lawrie
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2006-01-05       Impact factor: 3.568

5.  Voxel-based study of structural changes in first-episode patients with bipolar disorder.

Authors:  Caleb M Adler; Melissa P DelBello; Kelly Jarvis; Ari Levine; John Adams; Stephen M Strakowski
Journal:  Biol Psychiatry       Date:  2006-10-06       Impact factor: 13.382

6.  Regional cerebral metabolism associated with anxiety symptoms in affective disorder patients.

Authors:  E A Osuch; T A Ketter; T A Kimbrell; M S George; B E Benson; M W Willis; P Herscovitch; R M Post
Journal:  Biol Psychiatry       Date:  2000-11-15       Impact factor: 13.382

7.  Reduced basal ganglia volumes after switching to olanzapine in chronically treated patients with schizophrenia.

Authors:  Donna J Lang; Lili C Kopala; Robert A Vandorpe; Qing Rui; Geoffrey N Smith; Vina M Goghari; Jocelyne S Lapointe; William G Honer
Journal:  Am J Psychiatry       Date:  2004-10       Impact factor: 18.112

8.  No differential effect of age on brain matter volume and cognition in bipolar patients and healthy individuals.

Authors:  Antonio Sarnicola; Matthew Kempton; Cristina Germanà; Morgan Haldane; Michael Hadjulis; Tessa Christodoulou; Athanasios Koukopoulos; Paolo Girardi; Roberto Tatarelli; Sophia Frangou
Journal:  Bipolar Disord       Date:  2009-03-06       Impact factor: 6.744

Review 9.  Do antipsychotic drugs affect brain structure? A systematic and critical review of MRI findings.

Authors:  S Navari; P Dazzan
Journal:  Psychol Med       Date:  2009-04-02       Impact factor: 7.723

10.  Voxel-based structural magnetic resonance imaging (MRI) study of patients with early onset schizophrenia.

Authors:  Yujiro Yoshihara; Genichi Sugihara; Hideo Matsumoto; John Suckling; Katsuhiko Nishimura; Takao Toyoda; Haruo Isoda; Kenji J Tsuchiya; Kiyokazu Takebayashi; Katsuaki Suzuki; Harumi Sakahara; Kazuhiko Nakamura; Norio Mori; Nori Takei
Journal:  Ann Gen Psychiatry       Date:  2008-12-22       Impact factor: 3.455

View more
  20 in total

1.  Morphometry of superior temporal gyrus and planum temporale in schizophrenia and psychotic bipolar disorder.

Authors:  J Tilak Ratnanather; Clare B Poynton; Dominic V Pisano; Britni Crocker; Elizabeth Postell; Shannon Cebron; Elvan Ceyhan; Nancy A Honeycutt; Pamela B Mahon; Patrick E Barta
Journal:  Schizophr Res       Date:  2013-09-06       Impact factor: 4.939

2.  Basal ganglia and thalamic morphology in schizophrenia and bipolar disorder.

Authors:  Fay Y Womer; Lei Wang; Kathryn I Alpert; Matthew J Smith; John G Csernansky; Deanna M Barch; Daniel Mamah
Journal:  Psychiatry Res       Date:  2014-06-06       Impact factor: 3.222

3.  Three-dimensional mapping of hippocampal and amygdalar structure in euthymic adults with bipolar disorder not treated with lithium.

Authors:  Lara C Foland-Ross; Paul M Thompson; Catherine A Sugar; Katherine L Narr; Conor Penfold; Roxanne E Vasquez; Jennifer Townsend; Jeffrey Fischer; Priya Saharan; Carrie E Bearden; Lori L Altshuler
Journal:  Psychiatry Res       Date:  2012-11-11       Impact factor: 3.222

4.  Morphometry-based measurements of the structural response to whole-brain radiation.

Authors:  D Fuentes; J Contreras; J Yu; R He; E Castillo; R Castillo; T Guerrero
Journal:  Int J Comput Assist Radiol Surg       Date:  2014-11-20       Impact factor: 2.924

5.  Overlapping and distinct gray and white matter abnormalities in schizophrenia and bipolar I disorder.

Authors:  Dana Anderson; Babak A Ardekani; Katherine E Burdick; Delbert G Robinson; Majnu John; Anil K Malhotra; Philip R Szeszko
Journal:  Bipolar Disord       Date:  2013-06-25       Impact factor: 6.744

6.  An MRI study of amygdala in schizophrenia and psychotic bipolar disorder.

Authors:  Pamela Belmonte Mahon; Haley Eldridge; Britni Crocker; Lisa Notes; Holly Gindes; Elizabeth Postell; Stacey King; James B Potash; J Tilak Ratnanather; Patrick E Barta
Journal:  Schizophr Res       Date:  2012-05-03       Impact factor: 4.939

Review 7.  Voxel-based morphometry for separation of schizophrenia from other types of psychosis in first episode psychosis.

Authors:  Lena Palaniyappan; Nicola Maayan; Hanna Bergman; Clare Davenport; Clive E Adams; Karla Soares-Weiser
Journal:  Cochrane Database Syst Rev       Date:  2015-08-07

8.  More pronounced deficits in facial emotion recognition for schizophrenia than bipolar disorder.

Authors:  Vina M Goghari; Scott R Sponheim
Journal:  Compr Psychiatry       Date:  2012-12-04       Impact factor: 3.735

Review 9.  Neuroanatomical voxel-based profile of schizophrenia and bipolar disorder.

Authors:  E Maggioni; M Bellani; A C Altamura; P Brambilla
Journal:  Epidemiol Psychiatr Sci       Date:  2016-04-20       Impact factor: 6.892

10.  Impairment in semantic retrieval is associated with symptoms in schizophrenia but not bipolar disorder.

Authors:  Sharna Jamadar; Kasey M O'Neil; Godfrey D Pearlson; Mahvesh Ansari; Adrienne Gill; Kanchana Jagannathan; Michal Assaf
Journal:  Biol Psychiatry       Date:  2012-09-15       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.